PHP
EW icon

Parkman Healthcare Partners’s Edwards Lifesciences EW Stock Holding History

Parkman Healthcare Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-167,155
Closed -$13.4M – 87
2026
Q1 		$13.4M Buy
167,155
+16,170
+11% +$1.33M 1.38% 24
2025
Q4 		$12.9M Sell
150,985
-4,781
-3% -$392K 1.23% 29
2025
Q3 		$12.1M Sell
155,766
-95,975
-38% -$7.5M 1.26% 28
2025
Q2 		$19.7M Buy
251,741
+50,922
+25% +$3.8M 2.26% 14
2025
Q1 		$14.6M Buy
200,819
+55,605
+38% +$3.98M 1.73% 22
2024
Q4 		$10.8M Buy
+145,214
New +$10.2M 1.43% 25
2023
Q4 		– Sell
-40,000
Closed -$2.77M – 97
2023
Q3 		$2.77M Buy
+40,000
New +$3.21M 0.51% 59
2023
Q1 		– Sell
-54,579
Closed -$4.07M – 87
2022
Q4 		$4.07M Sell
54,579
-27,327
-33% -$2.11M 1.08% 38
2022
Q3 		$6.77M Buy
+81,906
New +$7.88M 1.92% 18
2021
Q1 		– Sell
-50,584
Closed -$4.62M – 89
2020
Q4 		$4.62M Sell
50,584
-71,947
-59% -$5.97M 1.18% 33
2020
Q3 		$9.78M Buy
122,531
+2,531
+2% +$197K 2.59% 8
2020
Q2 		$8.29M Buy
+120,000
New +$8.53M 2.34% 12

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Parkman Healthcare Partners's EW Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 167,155 shares — an estimated $13.4M sold.

Parkman Healthcare Partners first reported a position in EW in Q2 2020 and held it in 12 quarters. The position peaked at $19.7M in Q2 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Parkman Healthcare Partners reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 167,155 Edwards Lifesciences shares in Q2 2026, an estimated $13.4M.
  • Parkman Healthcare Partners first reported a position in Edwards Lifesciences in Q2 2020 and held it in 12 quarters.
  • Parkman Healthcare Partners's Edwards Lifesciences position peaked at $19.7M in Q2 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.